Circio
Regenerative Medicine · Cell & Gene Therapy
Overview
Circio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Funding and backers
Total raised
$10.7M
1 round on record
Latest round
$10.7M
Venture round · Dec 2024 · 22 mo ago
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 18, 2024
Raised a round Venture round $10.7M · News Powered by Cision
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $10.7M | — | News Powered by Cision |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
Avigen develops cellular avidity tools for immunotherapy and cell therapy R&D, helping identify potent and safe lead drug candidates faster.
Home About Us Science & Service Our Team Updates News & Updates Publications Blog Products Contact Us ABOUT US ABOUT US about Exsure Our…
A global cellular medicine company headquartered in New York, USA focussed on developing proprietary ‘off-the-shelf’ allogenic cell…
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with…
Financials
Total raised
$10.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $10.7M | Details |
News
Circio boosts circVec gene therapy data and secures funding runway to 2030
Tipranks Press Release.
Read more
Report
Circio and Avenue Biosciences announce research collaboration to enhance protein secretion for gene therapy
Circio and Avenue Biosciences announce research collaboration to enhance protein secretion for gene therapy
Read more
Report
Circio announces 88% underwritten and presubscribed NOK 50 million rights issue with strong support from existing shareholders
Read more
Report
Circio raises NOK 10.7 million in upsized offering from new and existing shareholders
Circio has raised a total of approx. NOK 10.7 million in new capital from the exercise of
Read more
Report
Circio announces financing that secures cash runway for twelve months
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR
Read more
Report
Show more news